TI role of eosinophils in inflammation and their mode of activation is not well understood. Eosinophil accumulation and subsequent expression of cytokines at the site of inflammation may play a role in exacerbation of inflammatory responses. In the present study, we have examined the role of TNF-a in eosinophil activation and chemokine production using a human leukaemic eosinophil cell line, EOL-1. Initial studies demonstrated that TNF-a induced the upregulation of IL-8 and MCP-1 mRNA and protein. Kinetic studies indicated production of chemokines, and MCP-1, as early as 4h post-activation, with peak levels of chemokine produced at 8h, and decreasing by 24h post-TNF-activation. When IL-10, a suppressive cytokine, was incubated with TNF-and EOL-1 cells, no effect was observed on IL-8 and MCP-1 production. However, dexamethasone, a glucocorticoid, demonstrated potent inhibitory effects on the EOL-l-derived chemokines. These studies indicate that eosinophils may be a significant source of chemokines capable of participating in, and maintaining, leukocyte recruitment during inflammatory responses, such as asthma.
Introduction
Eosinophils are granule-containing cells that differentiate from stem cell precursors in the bone marrow, circulate in the blood, and then enter into peripheral tissues. 1'2 Normally present at low concentrations, increased levels of circulating and/or tissue eosinophils have been associated with diseases such as asthma and parasitic infections. 2'3 The presence of eosinophils during chronic inflammatory diseases has been associated with tissue pathology. In addition, eosinophils represent a potential source of cytokines that may influence chronic inflammatory reactions and other biological responses. The establishment of a human eosinophilic leukaemia cell line, EOL-1, has proved to be a useful in vitro model for studying the properties of eosinophils and the pathways of their inflammatory responses and released products.
Cytokines regulate immunologic and physiologic events by transmitting information to target cells through receptor-ligand interactions. 4 For example, it has been shown previously that interleukin-1 (IL-1) and tumour necrosis factor-or (TNF-cz) act as early response cytokines and can stimulate a variety of both immune and nonimmune cells to produce additional peptide mediators, some of which have been shown to 218 Mediators of Inflammation Vol 5 1996 be important leukocyte chemotactic factors. [4] [5] [6] These chemotactic cytokines, or chemokines, which recruit additional cells to the inflammatory site, can be divided into two polypeptide groups based on the position of two internal disulfide bonds formed from four cysteine amino acid residues. In one supergene family of chemokines (C-C chemokine family), exemplified by the 
